What Researchers Did
Researchers presented two cases of cyclophosphamide-induced hemorrhagic cystitis that were refractory to standard treatments and were subsequently treated with hyperbaric oxygen therapy.
What They Found
Both patients, who had hemorrhagic cystitis refractory to hyperhydration and bladder irrigation, received 20 to 30 daily sessions of hyperbaric oxygen therapy. Both patients reported improved symptoms within the first 15 sessions, and their hematuria diminished by 20 sessions.
What This Means for Canadian Patients
For Canadian patients experiencing cyclophosphamide-induced hemorrhagic cystitis that does not respond to standard treatments, hyperbaric oxygen therapy could be a less invasive outpatient treatment option. This therapy may provide symptom relief and reduce hematuria, potentially improving quality of life for those with refractory cases.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or by Canadian researchers.
Study Limitations
A significant limitation of this study is its small sample size, as it only presents two case reports.